Genes
Oligo Pools
NGS
Variant Libraries
Antibodies
IVDR Solutions
Application Note
Webinar
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Drugging the undruggable with protein interference
Presented by
Dr. Benedict Cross
CTO, PhoreMost
Covered in this Webinar
Hear how SITESEEKER® exploits protein interference (PROTEINi)
See how the path from target ID to drug development can be shortened
Discover how this technology can be applied in cancer biology and neurodegeneration
Learn why the length and fidelity of Twist Oligo Pools is enabling the next generation of the platform
In the post-genome era, large-scale, gene-centric target discovery studies using tools such as RNAi and CRISPR have proliferated, and produced many insights into disease biology. Challenges remain however, as these tools often struggle to interrogate the subtle biological processes that govern clinical response. Fortunately, new screening tools exist that can both find targets and uncover the mechanisms that modulate complex molecular interactions. One such tool is SITESEEKER®, developed by the scientists at PhoreMost.
In this webinar you will:
- Hear how SITESEEKER® exploits protein interference (PROTEINi) to deliver a substantially greater magnitude of complexity than existing screening tools.
- See how the path from target ID to drug development can be shortened using PROTEINi, through the discovery of druggable pockets in addition to targets.
- Discover how this technology can be applied in key disease areas, including in cancer biology, neurodegeneration and for hijacking targeted protein degradation.
- Learn why the length and fidelity of Twist Oligo Pools is enabling PhoreMost to develop the next generation of their platform.
Share your details to Watch the Webinar
